銆€銆€缁忚繃璇勪及锛岃浆鍩哄洜灏忕粍寰楀嚭缁撹锛屽氨瀵逛汉绫诲拰鍔ㄧ墿鍋ュ悍鍙婄幆澧冪殑娼滃湪褰卞搷鑰岃█锛岃浆鍩哄洜鐜夌背DAS1131涓庡叾浼犵粺瀵瑰簲鍝佺鍜岀粡杩囨祴璇曠殑闈炶浆鍩哄洜鐜夌背鍝佺涓€鏍峰畨鍏ㄣ€傞儴鍒嗗師鏂囨姤閬撳涓嬶細
銆€銆€Genetically modified maize DAS1131 was developed to co
nfer resistance to certain susceptible lepidopteran pests, as well as tolerance to glyphosate herbicide, these properties were achieved by introducing the cry1Da2 and dgt-28 epsps ex
pression cassettes. The molecular characterisation data and bioinformatic analyses do not identify issues requiring food/feed safety assessment. None of the identified differences in the agronomic/phenotypic and compositio
nal characteristics tested between maize DAS1131 and its co
nventional counterpart needs further assessment, except for crude fat in grain which does not raise safety and nutritio
nal concerns. The Panel on Genetically Modified Organisms (GMO Panel) does not identify safety co
ncerns regarding the toxicity and allergenicity of the Cry1Da2 and DGT-28 EPSPS proteins as expressed in maize DAS1131 and finds no evidence that the genetic modification would change the overall allergenicity of maize DAS1131. In the co
ntext of this application, the co
nsumption of food and feed from maize DAS1131 does not represent a nutritio
nal co
ncern in humans and animals. The GMO Panel co
ncludes that maize DAS1131 is as safe as the co
nventional counterpart and the non-GM maize varieties tested, and no post-market mo
nitoring of food/feed is co
nsidered necessary. In the case of release of maize DAS1131 into the environment, including viable grains, this would not raise enviro
nmental safety concerns. The post-market enviro
nmental mo
nitoring plan and reporting intervals are in line with the intended uses of maize DAS1131. The GMO Panel co
ncludes that maize DAS1131 is as safe as its co
nventional counterpart and the tested non-GM maize varieties with respect to potential effects on human and animal health and the environment.
銆€銆€
鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝鏈変换浣曠枒闂紝璇疯仈绯籲ews@www.sqrdapp.com銆侟/span>